SWOG clinical trial number
SWOG-8421
Cyclophosphamide, Methotrexate and 5-Fluorouracil in the Treatment of Stage D2 Adenocarcinoma of the Prostate TEMPORARILY CLOSED: 6/14/85
Closed
Phase
Published
Abbreviated Title
Cyclophosphamide, Methotrexate and 5-Fluorouracil in the Treatment of Stage D2 Adenocarcinoma of the Prostate TEMPORARILY CLOSED: 6/14/85
Activated
01/11/1985
Closed
09/27/1985
Publication Information Expand/Collapse
1993
Cyclophosphamide, methotrexate and 5-fluorouracil in the treatment of metastatic prostate cancer: A Southwest Oncology Group study.